Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 146.00
-3.60 (-2.41%)
Aug 15, 2025, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.42 billion as of August 15, 2025. Its market cap has increased by 30.05% in one year.
Market Cap
2.42B
Enterprise Value
2.38B
Revenue
235.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
146.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.42B, an increase of 79.21%. That is a compound annual growth rate of 17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 2.42B | 23.82% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.91B |
| Sectra AB | 66.82B |
| Getinge AB | 54.96B |
| Medicover AB | 41.37B |
| Camurus AB | 38.30B |
| Asker Healthcare Group AB | 37.84B |
| BioArctic AB | 20.66B |
| Bonesupport Holding AB | 20.11B |